| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.3 | 2e-09 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | 0.2 | 3e-07 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.19 | 7e-07 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-06 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.17 | 8e-06 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | 0.22 | 5e-05 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.19 | 0.0001 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0001 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0001 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0002 |